Printer Friendly
The Free Library
19,595,260 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Astrazeneca Deals Briefing Covered 106 Deals Made between 2000 and 2005.


DUBLIN Dublin, city, Republic of Ireland
Dublin, Irish Baile Átha Cliath, county borough (1991 pop. 915,516), Leinster, capital of the Republic of Ireland, on Dublin Bay at the mouth of the Liffey River.
, Ireland Ireland, Irish Eire (âr`ə) [to it are related the poetic Erin and perhaps the Latin Hibernia], island, 32,598 sq mi (84,429 sq km), second largest of the British Isles.  -- Research and Markets (http://www.researchandmarkets.com/reports/c26120 ) has announced the addition of AstraZeneca AstraZeneca PLC[1] (LSE: AZN, ), is a large Anglo-Swedish pharmaceutical company formed on 6 April 1999 by the merger of Swedish Astra AB and British Zeneca Group PLC.  Deals Briefing to their offering.

-- Description

AstraZeneca Deals Briefing provides an in-depth in-depth
adj.
Detailed; thorough: an in-depth study.


in-depth
Adjective

detailed or thorough: an in-depth analysis

 view of the 106 deals made by AstraZeneca and its subsidiaries with 113 partnering companies between 2000 and 2005, in a clear and accessible PDF (Portable Document Format) The de facto standard for document publishing from Adobe. On the Web, there are countless brochures, data sheets, white papers and technical manuals in the PDF format.  format.

Chapter 1: Company profile

An overview of the company, including contact details, a summary of business and partnering interests, and a review of management

Chapter 2: Financial data and deals overview

A summary of the company's financial status and overview of the numbers of deals by deal type, therapy focus, deal stage and industry sector.

Chapter 3: Summary of deals

A comprehensive overview listing deals by partner company, therapy focus and development stage, with a full index of all the deals announced.

Chapter 4: List of deals

A detailed listing of all the company's deals and alliances announced between January January: see month.  2000 and July July: see month.  2005.

*Pharmaceutical Executive Top 50, May 2005

Every deal is fully categorized cat·e·go·rize  
tr.v. cat·e·go·rized, cat·e·go·riz·ing, cat·e·go·riz·es
To put into a category or categories; classify.



cat
, includes a detailed description, and includes financials such as headline value, upfront payments and royalty rates, where disclosed dis·close  
tr.v. dis·closed, dis·clos·ing, dis·clos·es
1. To expose to view, as by removing a cover; uncover.

2. To make known (something heretofore kept secret).
.
-- Scope
The report contains:
a brief company profile including subsidiary names
financial information where disclosed
a deals overview
specialized indexes including deals by partner company, subsidiary
company, therapy focus and development stage
a detailed listing of the company's deals and alliances.

-- Key questions answered
AstraZeneca Deals briefing provides a comprehensive summary of the
deals and alliances announced by the company and its subsidiaries
between January 2000 and July 2005. This report helps in:
identifying active partners
tracking competitor activity
benchmarking deals
comparing the finances of different deal types.

AstraZeneca Deals briefing brings all relevant partnering deals into
one place, providing a reference to deal making by AstraZeneca.

-- Forecasts, projections, market estimates
This report provides: a financial summary table detailing the
yearly total revenues, pharma revenues, R&D spend and profit of the
company; and a series of tables detailing the number of deals made
by deal type, by therapy focus, by development stage and by
industry sector.

-- Who the report is aimed at
This report is essential reading for board and executive management,
and individuals in:
business development
licensing/partnering
deal making
business strategy
marketing and promotion
distribution and manufacturing (including contract services).

Topics Covered
Introduction
About Partneringdesk Deals briefings
Chapter 1: Company profile
Chapter 2: Financial data and deals overview
Chapter 3: Summary of deals
Deals involving AstraZeneca by partner company
Deals involving AstraZeneca by subsidiary
Deals involving AstraZeneca by therapy focus
Deals involving AstraZeneca by development stage
Chapter 4: List of deals
Glossary
List of Tables and Charts

Companies Mentioned
AstraZeneca R&D Boston
Zeneca


For more information visit http://www.researchandmarkets.com/reports/c26120
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Oct 19, 2005
Words:455
Previous Article:Beacon Equity Research Initiates Coverage of Sense Holdings Targeting Share Price to Approximately Double to $0.75; Report Details Company's Advanced...
Next Article:Gina Boswell Elected to Applebee's International's Board of Directors.
Topics:



Related Articles
Wolters Kluwer acquires Casenotes Publishing Co.
Credit union thief receives probation.
The Chronicler as Author. Studies in Text and Texture. (Briefly Noted).
Mealey launches "Construction Defects Insurance Report".
Oxford University Press acquires two journals; launch in 2006.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles